Immediate Impact
2 from Science/Nature 58 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Trina Lum being referenced
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Trina Lum | 547 | 320 | 180 | 237 | 24 | 884 | |
| Karwan Moutasim | 443 | 432 | 111 | 183 | 33 | 1.0k | |
| Maher N. Younes | 493 | 514 | 94 | 154 | 21 | 1.1k | |
| Yansong Bian | 392 | 579 | 252 | 180 | 23 | 986 | |
| Chiao‐Ying Lin | 407 | 435 | 184 | 85 | 16 | 847 | |
| Lars Tharun | 421 | 449 | 139 | 231 | 39 | 921 | |
| Stephen B. Keysar | 553 | 566 | 63 | 260 | 30 | 1.1k | |
| Stephanie Petrillo | 283 | 385 | 93 | 116 | 38 | 766 | |
| Anette Weber | 482 | 368 | 249 | 86 | 18 | 866 | |
| Elena Leonardi | 509 | 334 | 164 | 146 | 31 | 1.0k | |
| Motokazu Suyama | 484 | 432 | 117 | 257 | 31 | 949 |
All Works
Login with ORCID to disown or claim papers
Loading papers...